Eiger BioPharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
-Infinity%
|
SQZ Biotechnologies Company
|
20.9 Million USD
|
87.217%
|
Evofem Biosciences, Inc.
|
8000.00 USD
|
-33310.025%
|
Santhera Pharmaceuticals Holding AG
|
1.75 Million USD
|
-52.255%
|
Mesoblast Limited
|
100.29 Million USD
|
97.335%
|
Propanc Biopharma, Inc.
|
58.64 Thousand USD
|
-4457.829%
|
Genus plc
|
228.2 Million USD
|
98.829%
|
VioQuest Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
CNBX Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Marizyme, Inc.
|
667.12 Thousand USD
|
-300.642%
|
ContraFect Corporation
|
2.21 Million USD
|
-20.941%
|
Nymox Pharmaceutical Corporation
|
- USD
|
-Infinity%
|
PsyBio Therapeutics Corp.
|
- USD
|
-Infinity%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
1.4 Million USD
|
-90.515%
|
Intellipharmaceutics International Inc.
|
- USD
|
-Infinity%
|
AXIM Biotechnologies, Inc.
|
5.42 Million USD
|
50.745%
|
MultiCell Technologies, Inc.
|
36.43 USD
|
-7336715.811%
|
Accustem Sciences Inc.
|
- USD
|
-Infinity%
|
RVL Pharmaceuticals plc
|
55.61 Million USD
|
95.194%
|
EV Biologics, Inc.
|
- USD
|
-Infinity%
|
Q BioMed Inc.
|
- USD
|
-Infinity%
|
Emmaus Life Sciences, Inc.
|
2.22 Million USD
|
-20.072%
|
Neon Bloom, Inc.
|
- USD
|
-Infinity%
|
Mosaic ImmunoEngineering Inc.
|
1.22 Million USD
|
-117.591%
|
Biomind Labs Inc.
|
- USD
|
-Infinity%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
-Infinity%
|
Pharming Group N.V.
|
166.1 Million USD
|
98.391%
|
Oncotelic Therapeutics, Inc.
|
1.89 Million USD
|
-40.787%
|
Skye Bioscience, Inc.
|
171.23 Thousand USD
|
-1460.943%
|
Therapeutic Solutions International, Inc.
|
5512.00 USD
|
-48390.602%
|
THC Farmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Arch Therapeutics, Inc.
|
- USD
|
-Infinity%
|
IMV Inc.
|
27.39 Million USD
|
90.245%
|
Acro Biomedical Co., Ltd.
|
- USD
|
-Infinity%
|
Curative Biotechnology, Inc.
|
- USD
|
-Infinity%
|
GB Sciences, Inc.
|
322 Thousand USD
|
-730.063%
|
Alpha Cognition Inc.
|
- USD
|
-Infinity%
|
HST Global, Inc.
|
- USD
|
-Infinity%
|
CSL Limited
|
11.23 Billion USD
|
99.976%
|
Halberd Corporation
|
150 Thousand USD
|
-1681.868%
|
Enzolytics Inc.
|
- USD
|
-Infinity%
|
Resverlogix Corp.
|
- USD
|
-Infinity%
|
Affymax, Inc.
|
- USD
|
-Infinity%
|
SYBLEU INC
|
300 Thousand USD
|
-790.934%
|
Nuo Therapeutics, Inc.
|
164.2 Thousand USD
|
-1527.723%
|
argenx SE
|
15.35 Million USD
|
82.592%
|
MetaStat, Inc.
|
- USD
|
-Infinity%
|
Northwest Biotherapeutics, Inc.
|
20.31 Million USD
|
86.841%
|
Enzon Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Arno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RespireRx Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
GeneThera, Inc.
|
- USD
|
-Infinity%
|
Inhibitor Therapeutics, Inc.
|
- USD
|
-Infinity%
|
AVAX Technologies, Inc.
|
- USD
|
-Infinity%
|
Zenith Capital Corp.
|
4456.00 USD
|
-59882.092%
|
Genscript Biotech Corporation
|
287.12 Million USD
|
99.069%
|
Ember Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sigyn Therapeutics, Inc.
|
126.3 Thousand USD
|
-2016.199%
|
WPD Pharmaceuticals Inc.
|
229.29 Thousand USD
|
-1065.681%
|
American Oriental Bioengineering, Inc.
|
554.59 Thousand USD
|
-381.942%
|
Provectus Biopharmaceuticals, Inc.
|
25.29 Thousand USD
|
-10464.852%
|
Adynxx, Inc.
|
- USD
|
-Infinity%
|
Helix BioMedix, Inc.
|
- USD
|
-Infinity%
|
GlobeStar Therapeutics Corporation
|
- USD
|
-Infinity%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
-Infinity%
|
Capstone Therapeutics Corp.
|
8.26 Million USD
|
67.657%
|
Cotinga Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
BioStem Technologies, Inc.
|
265.63 Thousand USD
|
-906.193%
|
ONE Bio Corp.
|
592.19 Thousand USD
|
-351.336%
|
Reve Technologies, Inc.
|
1064.00 USD
|
-251103.195%
|
Burzynski Research Institute, Inc.
|
- USD
|
-Infinity%
|
Wesana Health Holdings Inc.
|
- USD
|
-Infinity%
|
Agentix Corp.
|
- USD
|
-Infinity%
|
LadRx Corporation
|
- USD
|
-Infinity%
|
Cell Source, Inc.
|
- USD
|
-Infinity%
|
ProtoKinetix, Incorporated
|
- USD
|
-Infinity%
|
Regen BioPharma, Inc.
|
149.61 Thousand USD
|
-1686.465%
|
Regen BioPharma, Inc.
|
149.61 Thousand USD
|
-1686.465%
|
NovAccess Global Inc.
|
- USD
|
-Infinity%
|
Endonovo Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Itoco Inc.
|
- USD
|
-Infinity%
|
Rasna Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Pathfinder Cell Therapy, Inc.
|
- USD
|
-Infinity%
|
Kadimastem Ltd
|
229.69 Thousand USD
|
-1063.651%
|
Oncology Pharma Inc.
|
- USD
|
-Infinity%
|
Institute of Biomedical Research Corp.
|
- USD
|
-Infinity%
|
CytoDyn Inc.
|
141 Thousand USD
|
-1795.604%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
NDT Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Mobile Lads Corp.
|
- USD
|
-Infinity%
|
NanoSphere Health Sciences Inc.
|
- USD
|
-Infinity%
|
Qrons Inc.
|
80 Thousand USD
|
-3241.003%
|
Alseres Pharmaceuticals, Inc.
|
7.81 Million USD
|
65.821%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
-Infinity%
|
Nascent Biotech, Inc.
|
- USD
|
-Infinity%
|
Rebus Holdings, Inc.
|
- USD
|
-Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
369.04 Thousand USD
|
-624.24%
|
International Stem Cell Corporation
|
445 Thousand USD
|
-500.63%
|
Bioxytran, Inc.
|
- USD
|
-Infinity%
|
GlobeImmune, Inc.
|
- USD
|
-Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
-Infinity%
|
ProText Mobility, Inc.
|
- USD
|
-Infinity%
|
Cardax, Inc.
|
- USD
|
-Infinity%
|
VG Life Sciences Inc.
|
- USD
|
-Infinity%
|
Kaleido Biosciences, Inc.
|
- USD
|
-Infinity%
|
Advaxis, Inc.
|
8.15 Million USD
|
67.205%
|
Adhera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RenovaCare, Inc.
|
- USD
|
-Infinity%
|
Regnum Corp.
|
- USD
|
-Infinity%
|
Innovation Pharmaceuticals Inc.
|
457 Thousand USD
|
-484.858%
|
Neutra Corp.
|
- USD
|
-Infinity%
|
Windtree Therapeutics, Inc.
|
1.16 Million USD
|
-130.216%
|
PureTech Health plc
|
18.25 Million USD
|
85.355%
|
Coeptis Therapeutics, Inc.
|
150 Thousand USD
|
-1681.868%
|
IXICO plc
|
275 Thousand USD
|
-871.928%
|
IntelGenx Technologies Corp.
|
11.83 Million USD
|
77.424%
|
Gelesis Holdings, Inc.
|
26.3 Million USD
|
89.841%
|
CSL Limited
|
11.23 Billion USD
|
99.976%
|
Cellectis S.A.
|
36.21 Million USD
|
92.619%
|